Resultados de procura - Seppo Ylä‐Herttuala

Limitar resultados
  1. 1
    Glybera's Second Act: The Curtain Rises on the High Cost of Therapy

    Glybera's Second Act: The Curtain Rises on the High Cost of Therapy por Seppo Ylä‐Herttuala

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Editorial
    Engadir a favoritos
    Gardado en:
  2. 2
    Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union

    Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union por Seppo Ylä‐Herttuala

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Editorial
    Engadir a favoritos
    Gardado en:
  3. 3
    Gene Therapy for Malignant Glioma: Current Clinical Status

    Gene Therapy for Malignant Glioma: Current Clinical Status por Kalevi Pulkkanen, Seppo Ylä‐Herttuala

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Current Status of Cardiovascular Gene Therapy

    Current Status of Cardiovascular Gene Therapy por Tuomas T. Rissanen, Seppo Ylä‐Herttuala

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Gene Therapy Used in Cancer Treatment

    Gene Therapy Used in Cancer Treatment por Thomas Wirth, Seppo Ylä‐Herttuala

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Cardiovascular Gene Therapy: Past, Present, and Future

    Cardiovascular Gene Therapy: Past, Present, and Future por Seppo Ylä‐Herttuala, Andrew H. Baker

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Progress and prospects: hurdles to cardiovascular gene therapy clinical trials

    Progress and prospects: hurdles to cardiovascular gene therapy clinical trials por Marja Hedman, Juha Hartikainen, Seppo Ylä‐Herttuala

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Biology of vascular endothelial growth factors

    Biology of vascular endothelial growth factors por Himadri Roy, Shalini Bhardwaj, Seppo Ylä‐Herttuala

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success

    Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success por Galina Dragneva, Petra Korpisalo, Seppo Ylä‐Herttuala

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety

    Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety por Aleksi J. Leikas, Seppo Ylä‐Herttuala, Juha Hartikainen

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Expression of LDL Receptor, VLDL Receptor, LDL Receptor–Related Protein, and Scavenger Receptor in Rabbit Atherosclerotic Lesions

    Expression of LDL Receptor, VLDL Receptor, LDL Receptor–Related Protein, and Scavenger Receptor in Rabbit Atherosclerotic Lesions por Timo P. Hiltunen, Jukka Luoma, T. Nikkari, Seppo Ylä‐Herttuala

    Publicado 1998
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Nucleic Acid–Based Therapies for Atherosclerosis

    Nucleic Acid–Based Therapies for Atherosclerosis por Petri I. Mäkinen, Anna‐Kaisa Ruotsalainen, Seppo Ylä‐Herttuala

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Antioxidant Gene Therapy for Cardiovascular Disease

    Antioxidant Gene Therapy for Cardiovascular Disease por Anna‐Liisa Levonen, Elisa Vähäkangas, Jonna K. Koponen, Seppo Ylä‐Herttuala

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart?gene therapy

    Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart?gene therapy por Jaakko O. Markkanen, Tuomas T. Rissanen, Annukka M. Kivelä, Seppo Ylä‐Herttuala

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease

    Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease por Arja T. Erkkilä, Outi Närvänen, Seppo Lehto, Matti Uusitupa, Seppo Ylä‐Herttuala

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Angiogenic gene therapy in cardiovascular diseases: dream or vision?

    Angiogenic gene therapy in cardiovascular diseases: dream or vision? por Seppo Ylä‐Herttuala, Charles R. Bridges, Michael G. Katz, Petra Korpisalo

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Differential but Complementary HIF1α and HIF2α Transcriptional Regulation

    Differential but Complementary HIF1α and HIF2α Transcriptional Regulation por Nicholas Downes, Nihay Laham-Karam, Minna U. Kaikkonen, Seppo Ylä‐Herttuala

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Hypoxia induces microRNA miR‐210 in vitro and in vivo

    Hypoxia induces microRNA miR‐210 in vitro and in vivo por Kati Pulkkinen, Tarja Malm, Mikko P. Turunen, Jari Koıstınaho, Seppo Ylä‐Herttuala

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo

    Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo por P. Lehtolainen, Kristiina Tyynelä, J Kannasto, Kari J. Airenne, Seppo Ylä‐Herttuala

    Publicado 2002
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Challenges in monoclonal antibody-based therapies

    Challenges in monoclonal antibody-based therapies por Haritha Samaranayake, Thomas Wirth, Diana Schenkwein, J K Räty, Seppo Ylä‐Herttuala

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: